Skip to main content
. 2021 Jan 6;5(1):e20.00185. doi: 10.5435/JAAOSGlobal-D-20-00185

Figure 1.

Figure 1

Clustered bar chart showing the percentage of users of each particular orthobiologic who believed that the product was efficacious when treating patients and percentage who attested to using a product because their competitors were using the product. Ad-MSC = adipose-derived mesenchymal stromal cells, AMP = amniotic membrane products, BMAC = bone marrow aspirate concentrate, PRP-LP = leukocyte-poor platelet-rich plasma, PRP-LR = leukocyte-rich platelet-rich plasma, UCD = umbilical cord–derived cell